ArticleExperimental and therapeutic medicine2021

ACTL6A knockdown inhibits cell migration by suppressing the AKT signaling pathway and enhances the sensitivity of glioma cells to temozolomide.

Xueru Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.